+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Frequency of prosthetic valve-related complications with very low level warfarin anticoagulation combined with dipyridamole after valve replacement using St. Jude medical prostheses



Frequency of prosthetic valve-related complications with very low level warfarin anticoagulation combined with dipyridamole after valve replacement using St. Jude medical prostheses



American Journal of Cardiology 74(11): 1137-1141



The safety of a very low level of anticoagulation combined with dipyridamole in a rheumatic population (mean age 31 +/- 13 years) with the St. Jude Medical (SJM) prosthesis has not yet been tested. Furthermore, no data are available on the safety of relatively infrequent monitoring of anticoagulation levels and of the necessity for different therapeutic targets according to valve position, number of risk factors, and other baseline risk factors for thromboembolism. In this study, the performance of the SJM prosthesis was tested using a target international normalized ratio (INR) of 2.0 to 2.5 combined with dipyridamole 300 mg/day applied uniformly to all patients. Clinical, biochemical, and echocardiographic data were acquired prospectively in 200 consecutive patients at 3-month intervals. Follow-up (mean 27 +/- 13 months) was complete in 95% of patients. Thirteen patients died (2.9%/patient year). Severe left ventricular dysfunction was the cause of death in 10 of 13 patients. Probability of survival (Kaplan-Meier) was 0.92 at 36 months and of event-free survival 0.84 at 36 months. The median INR was 2.0 +/- 0.9. Valve obstruction did not occur, and there were 3 thromboembolic events (0.6%/patient year). Incidence of bleeding was 1.6%/patient year (n = 7) and was major (hemorrhagic stroke) in 1 (0.2%/patient year). Thus, the SJM prosthesis performs very well despite the use of very low level warfarin anticoagulation combined with dipyridamole. A 3-month assessment of the anticoagulation level is safe. Left ventricular dysfunction rather than valve-related complications is the leading cause of mortality in this population.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008704732

Download citation: RISBibTeXText

PMID: 7977074

DOI: 10.1016/0002-9149(94)90467-7


Related references

Frequency of prostate specific antigen mRNA expression in lung tumors. Clinical Chemistry 43(6 Part 2): S231, 1997

Combined vitamin D3/retinoic acid induction of human promyelocytic cell lines: enhanced phagocytic cell maturation and hybrid granulomonocytic phenotype. Cell Growth and Differentiation 6(5): 493-503, 1995

Comparative studies of hemo perfusion devices 2 pressure drop and flow uniformity tests. Biomaterials Medical Devices and Artificial Organs: 443-454, 1979

Hemodynamic patterns of pharmacologically induced erection: Evaluation by color Doppler sonography. Journal of Urology 159(1): 109-112, 1998

Frequency and severity of hepatitis C virus after liver transplantation: A study in 28 patients. Gastroenterologie Clinique et Biologique 19(8-9): 692-697, 1995

Predictive value of [-2]propsa (p2psa) and its derivatives for the prostate cancer detection in the 2.0 to 10.0ng/mL PSA range. International Braz J Urol 43(1): 48-56, 2017

Predictive value of prostatic adenocarcinoma after a negative prostate biopsy. BJU International 98(5): 986-988, 2000

The experience of application of the phone character method iv. the results of using the phone character the number of leaves in the rosette. Genetika 21(9): 1499-1502, 1985

Trial of clinical administration of a new antibacterial substance dl 8280 9 fluoro 3 methyl 10 4 methyl 1 piperazinyl 7 oxo 2 3 dihydro 7h pyrido 1 2 3 de 1 4 benzazine 6 carboxylic acid on patients with pulmonary tuberculosis. Kekkaku 59(9): 477-482, 1984

Operative results of hepatic lobectomy for primary hepatoma. Journal of Japan Society for Cancer Therapy 17(2): 316, 1982

Combined mitral and aortic valve defects in a patient with a single coronary artery. Contribution to the pathogenesis of cardiac hypertrophy. Kardiologia Polska 29(1): 48-54, 1986

Study on postanesthetic infusion technic in the surgery of children. Keisei Geka. Plastic and Reconstructive Surgery 9(2): 133-144, 1966

Preliminary clinical and experimental studies on benzanthrone toxicity. Journal of the Indian Medical Association 52(12): 558-560, 1969

Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 295(3): 293-298, 2006

Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators. American Journal of Cardiology 79(3): 286-291, 1997